D-optimal mixture design for optimization of topical dapsone niosomes: in vitro characterization and in vivo activity against Cutibacterium acnes

BA Habib, NF Abdeltawab, I Salah Ad-Din - Drug Delivery, 2022 - Taylor & Francis
This study aimed to illustrate the use of D-optimal mixture design (DOMD) for optimization of
an enhancer containing Dapsone niosomal formula for acne topical treatment. Mixture …

Enhanced transdermal delivery of ondansetron using nanovesicular systems: fabrication, characterization, optimization and ex-vivo permeation study-Box-Cox …

BA Habib, S Sayed, GM Elsayed - European journal of pharmaceutical …, 2018 - Elsevier
This study aimed to formulate suitable nanovesicles (NVs) for transdermal delivery of
Ondansetron. It also illustrated a practical example for the importance of Box-Cox …

Enhanced transdermal permeation of BCS class IV aprepitant using binary ethosome: Optimization, characterization and ex vivo permeation

DMN Abouhussein - Journal of drug delivery science and technology, 2021 - Elsevier
Aprepitant (APR) belongs to the Biopharmaceutics Classification System (BCS) class IV that
is characterized by both low solubility and permeability. This study aims to develop a new …

Ketorolac trometamol topical formulations: release behaviour, physical characterization, skin permeation, efficacy and gastric safety

DA El-Setouhy… - Journal of Pharmacy and …, 2010 - academic.oup.com
Objectives The objective of this study was to improve systemic delivery of the highly
analgesic ketorolac trometamol (ketorolac tromethamine) via the transdermal route, through …

Current Status and Future Perspective of Transferosomes-an Effective Vesicular Carrier for Delivery of Drugs

K Kiranjeet, K Gurpreet, S Hanum, N Ravika… - Journal of Coastal Life …, 2022 - jclmm.com
Transferosomes, a vesicular carrier has evolved as a very effective carrier for the delivery of
therapeutics, both for topical application as well as for transdermal application. It has been …

FRACTIONAL FACTORIAL DESIGN APPROACH FOR STUDYING IN VITRO TRANSDERMAL DELIVERY OF GRANISETRON USING ELECTROPORATION

SA NOUR, MT ELEWA, A El-rehim… - Al-Azhar Bulletin of …, 2008 - journals.ekb.eg
Granisetron Hydrochloride is a 5-hydroxytryptamine 3 (5-HT3) receptor antagonist used for
the prevention and treatment of nausea and vomiting associated with cancer chemotherapy …